secwatch / observer
8-K filed July 11, 2023, 7:59 PM ET ticker JBIO CIK 0001798749
leadership confidence high sentiment positive materiality 0.55

Aerovate appoints former Acceleron CEO Habib Dable to Board of Directors

Jade Biosciences, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Habib J. Dable

Director
JBIO · Jade Biosciences, Inc.
Effective
2023-07-10
Filed
July 11, 2023, 7:59 PM ET
Effective as of July 10, 2023 (the “Effective Date”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of Aerovate Therapeutics, Inc. (the “Company”), the Board appointed Habib J. Dable as a member of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Habib J. Dable was appointed as Director at Jade Biosciences, Inc..

Action
appointed
Role
Director
Exact text from the filing
Effective as of July 10, 2023 (the “Effective Date”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of Aerovate Therapeutics, Inc. (the “Company”), the Board appointed Habib J. Dable as a member of the Board.
View on SEC.gov

Jade Biosciences, Inc. filing history →

Source: SEC EDGAR
accession 0001798749-23-000048
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.